Back to top

Novo Nordisk’s New Obesity Metabolism Trial: What Investors Should Watch

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study The Effect of Once-weekly Subcutaneous NNC0487-0111 Compared to ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novo Nordisk A/S (NVO)